Bo Hu

Bo Hu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
KBKenneth B. Baker
Kenneth B. Baker
EPEla B. Plow
Ela B. Plow
SNSean Nagel
Sean Nagel
ARAnson B. Rosenfeldt
Anson B. Rosenfeldt
RGRaghavan Gopalakrishnan
Raghavan Gopalakrishnan
AMAndré G. Machado
André G. Machado
Upper-extremity impairment after stroke remains a major therapeutic challenge and a target of neuromodulation treatment efforts. In this open-label, non-randomized phase I trial, we applied deep brain stimulation to the cerebellar dentate nucleus combined with renewed physical rehabilitation to promote functional reorganization of ipsilesional cortex in 12 individuals with persistent (1–3 years), moderate-to-severe upper-extremity impairment. No serious perioperative or stimulation-related adverse events were encountered, with participants demonstrating a seven-point median improvement on the Upper-Extremity Fugl-Meyer Assessment. All individuals who enrolled with partial preservation of distal motor function exceeded minimal clinically important difference regardless of time since stroke, with a median improvement of 15 Upper-Extremity Fugl-Meyer Assessment points. These robust functional gains were directly correlated with cortical reorganization evidenced by increased ipsilesional metabolism. Our findings support the safety and feasibility of deep brain stimulation to the cerebellar dentate nucleus as a promising tool for modulation of late-stage neuroplasticity for functional recovery and the need for larger clinical trials. ClinicalTrials.gov registration: NCT02835443 .

1 January 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YLYuan Liu
Yuan Liu
HCHongguang Chen
Hongguang Chen
NZNan Zhang
Nan Zhang
XWXing Wang
Xing Wang
QFQinyi Fan
Qinyi Fan
MLMengqian Li
Mengqian Li

9 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJae-Ho Cheong
Jae-Ho Cheong
SWSam C. Wang
Sam C. Wang
SPSunho Park
Sunho Park
MPMatthew R. Porembka
Matthew R. Porembka
ACAlana L. Christie
Alana L. Christie
THTae Hyun Hwang
Tae Hyun Hwang
Genomic profiling can provide prognostic and predictive information to guide clinical care. Biomarkers that reliably predict patient response to chemotherapy and immune checkpoint inhibition in gastric cancer are lacking. In this retrospective analysis, we use our machine learning algorithm NTriPath to identify a gastric-cancer specific 32-gene signature. Using unsupervised clustering on expression levels of these 32 genes in tumors from 567 patients, we identify four molecular subtypes that are prognostic for survival. We then built a support vector machine with linear kernel to generate a risk score that is prognostic for five-year overall survival and validate the risk score using three independent datasets. We also find that the molecular subtypes predict response to adjuvant 5-fluorouracil and platinum therapy after gastrectomy and to immune checkpoint inhibitors in patients with metastatic or recurrent disease. In sum, we show that the 32-gene signature is a promising prognostic and predictive biomarker to guide the clinical care of gastric cancer patients and should be validated using large patient cohorts in a prospective manner.

23 November 2020 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
XWXing Wang
Xing Wang
HCHongguang Chen
Hongguang Chen
LLLing Liu
Ling Liu
YLYuan Liu
Yuan Liu
NZNan Zhang
Nan Zhang
MLMengqian Li
Mengqian Li
This study aimed to explore the psychological situation and the influence of the outbreak of COVID-19 on college students. An online questionnaire survey was conducted among 3,092 Chinese college students who were quarantined at home as a result of the COVID-19 pandemic. The survey tools included the Generalized Anxiety Disorder 7-Item Scale (GAD-7), the Perceived Stress Scale (PSS-10), and the Self-Rating Scale of Sleep (SRSS). Of all the respondents, the prevalence of anxiety symptoms, sleep problems, any of the two, and both of the two, were 16.8, 13.5, 25.1, and 5.3%, respectively. Of the participants, 43.7% of the college students had higher perceived stress. Factors associated with anxiety symptoms included reading the daily news with higher frequency (1–3 times; 4–7 times; more than 7 times), having sleep problems, higher stress, and carelessness with the number of remaining masks. Factors associated with sleep problems included postgraduates, reading the news with higher frequency daily (1–3 times), the frequency of going out per week (1–3 times), having anxiety symptoms and higher stress. Factors associated with higher perceived stress included reading the daily news with higher frequency (4–7 times), anxiety about the number of remaining masks (1–10; more than 20), having anxiety symptoms, and having sleep problems. The prevalence of anxiety symptoms, sleep problems, and higher perceived stress among college students was high during the COVID-19 outbreak. Particular attention should be paid to psychological support for college students quarantined at home, especially those at high risk of psychological problems.

14 February 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
HRHooman H. Rashidi
Hooman H. Rashidi
SASamer Albahra
Samer Albahra
SRScott Robertson
Scott Robertson
NTNam K. Tran
Nam K. Tran
BHBo Hu
Bo Hu
One of the core elements of Machine Learning (ML) is statistics and its embedded foundational rules and without its appropriate integration, ML as we know would not exist. Various aspects of ML platforms are based on statistical rules and most notably the end results of the ML model performance cannot be objectively assessed without appropriate statistical measurements. The scope of statistics within the ML realm is rather broad and cannot be adequately covered in a single review article. Therefore, here we will mainly focus on the common statistical concepts that pertain to supervised ML (i.e. classification and regression) along with their interdependencies and certain limitations.

25 June 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Mohammad AlyamaniMohammad Alyamani
Mohammad Alyamani
HEHamid Emamekhoo
Hamid Emamekhoo
SPSunho Park
Sunho Park
JTJennifer Taylor
Jennifer Taylor
NANima Almassi
Nima Almassi
NSNima Sharifi
Nima Sharifi
BACKGROUND. A common germline variant in HSD3B1(1245A>C) encodes for a hyperactive 3β-hydroxysteroid dehydrogenase 1 (3βHSD1) missense that increases metabolic flux from extragonadal precursor steroids to DHT synthesis in prostate cancer. Enabling of extragonadal DHT synthesis by HSD3B1(1245C) predicts for more rapid clinical resistance to castration and sensitivity to extragonadal androgen synthesis inhibition. HSD3B1(1245C) thus appears to define a subgroup of patients who benefit from blocking extragonadal androgens. However, abiraterone, which is administered to block extragonadal androgens, is a steroidal drug that is metabolized by 3βHSD1 to multiple steroidal metabolites, including 3-keto-5α-abiraterone, which stimulates the androgen receptor. Our objective was to determine if HSD3B1(1245C) inheritance is associated with increased 3-keto-5α-abiraterone synthesis in patients. METHODS. First, we characterized the pharmacokinetics of 7 steroidal abiraterone metabolites in 15 healthy volunteers. Second, we determined the association between serum 3-keto-5α-abiraterone levels and HSD3B1 genotype in 30 patients treated with abiraterone acetate (AA) after correcting for the determined pharmacokinetics. RESULTS. Patients who inherit 0, 1, and 2 copies of HSD3B1(1245C) have a stepwise increase in normalized 3-keto-5α-abiraterone (0.04 ng/ml, 2.60 ng/ml, and 2.70 ng/ml, respectively; P = 0.002). CONCLUSION. Increased generation of 3-keto-5α-abiraterone in patients with HSD3B1(1245C) might partially negate abiraterone benefits in these patients who are otherwise more likely to benefit from CYP17A1 inhibition. FUNDING. Prostate Cancer Foundation Challenge Award, National Cancer Institute.